The bad news for those who have hopes of the field is that Geron, an American firm that was a pioneer of the therapeutic use of stem cells, is pulling out of the business.

支持干细胞研究的人士听到了一个坏消息，Geron这家一度倡导干细胞治疗研究的美国公司，不打算做这方面研究。